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Abstract
Background: Smartphone-based assessment may be a useful diagnostic and monitoring tool for patients. There have been many
attempts to create a smartphone diagnostic tool for clinical use in various medical fields but few have demonstrated scientific
validity.
Objective: The purpose of this study was to develop a smartphone application of the International Prostate Symptom Score
(IPSS) and to demonstrate its validity and reliability.
Methods: From June 2012 to May 2013, a total of 1581 male participants (≥40 years old), with or without lower urinary tract
symptoms (LUTS), visited our urology clinic via the health improvement center at Soonchunhyang University Hospital (Republic
of Korea) and were enrolled in this study. A randomized repeated measures crossover design was employed using a smartphone
application of the IPSS and the conventional paper form of the IPSS. Paired t test under a hypothesis of non-inferior trial was
conducted. For the reliability test, the intraclass correlation coefficient (ICC) was measured.
Results: The total score of the IPSS (P=.289) and each item of the IPSS (P=.157-1.000) showed no differences between the
paper version and the smartphone version of the IPSS. The mild, moderate, and severe LUTS groups showed no differences
between the two versions of the IPSS. A significant correlation was noted in the total group (ICC=.935, P<.001). The mild,
moderate, and severe LUTS groups also showed significant correlations (ICC=.616, .549, and .548 respectively, all P<.001).There
was selection bias in this study, as only participants who had smartphones could participate.
Conclusions: The validity and reliability of the smartphone application version were comparable to the conventional paper
version of the IPSS. The smartphone application of the IPSS could be an effective method for measuring lower urinary tract
symptoms.
(J Med Internet Res 2014;16(2):e38)   doi:10.2196/jmir.3042
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Introduction
Lower urinary tract symptoms (LUTS) suggestive of benign
prostatic hyperplasia (BPH) affect a majority of men and show
an increasing prevalence with aging [1]. Male patients with
LUTS suffer from significant impairment of their quality of life
(QOL) and interference in daily living activities due to urinary
dysfunction [2].
The primary treatment goal for men with clinical manifestations
of BPH is to reduce or relieve LUTS. Therefore, the
measurement of LUTS is a key factor in the evaluation of these
patients, both in clinical practice and in research studies [2,3].
The International Prostate Symptom Score (IPSS) is the most
widely used diagnostic tool in urology and is widely available,
validated, and has been translated into many languages [3]. The
IPSS scale correlates positively and significantly with global
measures of difficulty and health complications associated with
LUTS [4-6].
To date, the paper-based IPSS has been used worldwide.
Although paper-based questionnaires have been the standard
tools for screening or monitoring of medical conditions, this
method has several problems, including data collection and
entry errors [7].
Over the past 20 years, questionnaires have been developed
using electronic systems, such as Web surveys on personal
computers or personal digital assistants, and more recently using
smartphones. There has been a meteoric rise in the use of
smartphones, which has reached approximately 6 billion people
worldwide [8], enabling smartphones to function as new tools
for measuring the health of individuals.
Most smartphone applications have focused on education and
communication for medical school students and clinicians [9].
However, several smartphone application questionnaires have
been introduced in clinical use, including psychiatry and sleep
disorders [10-12].Considering the worldwide use of the IPSS
in clinical fields, a smartphone application of the IPSS could
be very popular, both for patients and clinicians.
The ultimate goal of smartphone-based assessment is the
establishment of a home diagnostic device that enables easy
screening and monitoring of a disease by scoring data and thus
reducing the time to diagnosis and treatment, as well as overall
costs. Most questionnaires are originally designed as paper-based
questionnaires and, therefore, validation of a smartphone-based
version is required due to the possibility of response bias
between paper and smartphone versions [13].The aim of this
study was to examine the validity and reliability of a smartphone
application version of the IPSS by quantitative analysis and to
show the satisfaction rate compared with the conventional paper
version of the IPSS.
Methods
Study Sample
From June 2012 to May 2013, 1581 male patients presenting
with LUTS (≥ 40 years old) visited our urology clinic via the
health improvement center at Soonchunhyang University
Hospital (Republic of Korea) and were enrolled in this study.
All patients underwent a complete history, physical examination,
and urinalysis, and completed an IPSS questionnaire. Patients
who had a history of cancer of any organ, neurologic diseases
or disorders, uncontrolled hypertension or diabetes, psychiatric
disorders, prostatic surgery, liver cirrhosis, or renal failure were
excluded from this study. Participant data were recorded in a
prospective database and the study was approved by the
Institutional Review Board of Soonchunhyang University
Hospital.
Methodology
A randomized repeated measures crossover design was
employed using the smartphone application and conventional
paper form of the IPSS. One investigator conducted face-to-face
interviews with all study participants, using structured
explanations. The Korean version of the IPSS has been verified
for relevance and reliability, and is the most popular diagnostic
instrument for LUTS in Korea [14]. There was a 1-week break
before and after completion of the alternative versions of the
IPSS in order to reduce carryover effects. Questionnaires were
randomly assigned to the smartphone or paper version of the
IPSS. The supervisors obtained oral informed consent from
participants before the study.
Developing the Smartphone Application of the IPSS
The smartphone application was specifically developed for
Android model smartphones (Android is the operating system
created by Google). While actively answering the IPSS in the
smartphone application, participants could go backward to
correct answers before they chose “save” to go on to the next
question or to finish the test. The responses on the smartphone
application of the IPSS were automatically transferred to the
database where only supervisors could access the information.
System Stability
For a successful study trial, the stability of the system providing
the application of the IPSS should be safe and stable. To this
end, the server manager closely monitored the system during
the performance of this trial. Prior to this trial, we conducted a
pilot test to check the stability of the smartphone application of
the IPSS and the data collection server.
Main Outcome for Validity
The overall hypothesis of this study was that participants would
find both the smartphone application and paper version of the
IPSS feasible and acceptable to use, which means that the
smartphone application of the IPSS would not be inferior to the
paper version of the IPSS. Validity was defined by
non-difference in the total score of the IPSS and in each item
of the IPSS.
Main Outcome for Reliability
Reliability referred to the consistency of IPSS scores obtained
by the same person between the paper and smartphone version.
There were many statistics available to measure reliability. The
reliability test was conducted by the intraclass correlation
coefficient (ICC). ICC was used to measure reliability for the
paper and smartphone IPSS scores and ranged from 0 (no
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agreement) to 1 (perfect agreement). Reliability was defined by
correlation between the two versions of the IPSS.
Delivery Method Compliance
In order to determine the compliance rate, the participation and
preference rates were investigated by specific questions at the
end of the trial: “Which method would you be willing to use to
complete the assessment more easily?” and “Which method
would you prefer?”
Power Calculation
The base of our sample size was dependent on the hypothesis
that a smartphone application of the IPSS was not inferior to
the conventional paper-based IPSS [15]. We used an alpha error
of .05 and beta error of .2. The calculated sample size was 980.
Considering a 10% decline or withdrawal rate, the minimal
sample size was calculated to be 1100.
Data Analysis
We analyzed differences by paired t test for the two pairs of
questionnaires. Reliability was assessed using ICC and a
two-way random effect model, assuming a single measurement
and absolute agreement. Statistical analyses were performed
using SPSS version 20.0 for Windows. All statistics were
two-tailed and P values <.05 were considered statistically
significant.
Preservation of Data Security
Individual or total scores were not accessible by participants
through their smartphones. After completing the paper version
of the IPSS, the data collector recorded the data after checking
the data transfer error and then sent the data to the statistician.
After completing the smartphone application of the IPSS, the
data were transferred automatically to the special server and
then sent to the statistician. After completing the analysis, all
information regarding the IPSS was removed by the supervisor.
Results
Basic Characteristics of the Participants
The mean age of the participants was 58.49 (SD 7.22). The
mean total score of the IPSS paper version was 11.04 (SD 7.76)
and the mean total IPSS score of the smartphone version was
11.03 (SD 7.77). There were 668 (42.25%, 668/1581) subjects
in the mild LUTS group, 643 (40.67%, 643/1581) subjects in
the moderate LUTS group, and 270 (17.08%, 270/1581) subjects
in the severe LUTS group (Table 1). The refusal rate in total
was 16 and there were 3 cases of missing data, so the final
allocation was 1581 cases (Figure 1).
The total rates of mild, moderate, and severe LUTS groups were
significantly different (P<.001). In the comparison of the rates
of these groups, the mild and moderate LUTS groups were not
different (P=.471), but there were significant differences
(P<.001) between the mild and severe LUTS groups and the
moderate and severe LUTS groups.
Figure 1. Flow chart of study participants.
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Table 1. Baseline characteristics (n=1581).
RangeMean (SD)n
40-7958.49 (7.22)1581Age
0-51.69 (1.61)1580Paper IPSSa Q1
0-51.57 (1.42)1581Paper IPSS Q2
0-51.63 (1.54)1579Paper IPSS Q3
0-51.32 (1.42)1579Paper IPSS Q4
0-52.30 (1.66)1581Paper IPSS Q5
0-51.27 (1.46)1580Paper IPSS Q6
0-71.28 (1.15)1581Paper IPSS Q7
0-3511.04 (7.77)1581Paper Total IPSS
0-62.77 (1.38)1546Paper QOLb
0-51.68 (1.61)1580Smartphone IPSS Q1
0-51.57 (1.42)1581Smartphone IPSS Q2
0–51.63 (1.54)1579Smartphone IPSS Q3
0-51.32 (1.42)1579Smartphone IPSS Q4
0-52.30 (1.67)1581Smartphone IPSS Q5
0-51.27 (1.46)1580Smartphone IPSS Q6
0-71.28 (1.16)1581Smartphone IPSS Q7
0-3511.03 (7.77)1581Smartphone Total IPSS
0-62.77 (1.37)1546Smartphone QOL
----668 (42.25%)Mild LUTSc
----643 (40.67%)Moderate LUTS
----270 (17.08%)Severe LUTS
aIPSS: International Prostate Symptom Score
bQOL: quality of life
cLUTS: lower urinary tract symptoms
Validation With Paired t Test
There were no differences in the overall total scores of the IPSS
(P=.289) and each item of the IPSS (P values =.157-1.000)
between the paper version of the IPSS and smartphone version
of the IPSS (Table 2). In the mild LUTS group, the total score
of the IPSS (P=.752) and each item of the IPSS (P values
=.157-1.000) showed no differences between the paper version
and the smartphone version of the IPSS (Table 3). In the
moderate LUTS group, the total score of the IPSS (P=.432) and
each item of the IPSS (P values =.103-1.000) showed no
differences between the paper version and the smartphone
version of the IPSS (Table 4). In the severe LUTS group, the
total score of the IPSS (P=.083) and each item of the IPSS (P
values =.158-1.000) showed no differences between the paper
version and the smartphone version of the IPSS (Table 5).
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Table 2. Paired t test between paper and smartphone IPSSa.
P valueSmartphone,
mean (SD)
Paper,
mean (SD)
.1571.68 (1.61)1.69 (1.61)IPSS Q1
.1661.57 (1.42)1.57 (1.42)IPSS Q2
.4351.63 (1.54)1.63 (1.54)IPSS Q3
.5781.32 (1.42)1.32 (1.42)IPSS Q4
.2232.30 (1.66)2.30 (1.66)IPSS Q5
1.0001.27 (1.46)1.27 (1.46)IPSS Q6
.3171.28 (1.16)1.28 (1.15)IPSS Q7
.28911.03 (7.77)11.04 (7.77)Total IPSS
.1802.77 (1.37)2.77 (1.38)IPSS QOLb
aIPSS: International Prostate Symptom Score
bQOL: quality of life
Table 3. Paired t test between paper and smartphone IPSSa in mild LUTSb.
P valueSmartphone,
mean (SD)
Paper,
mean (SD)
1.0000.53 (0.71)0.53 (0.71)IPSS Q1
.7060.60 (0.71)0.60 (0.71)IPSS Q2
.1570.53 (0.66)0.53 (0.67)IPSS Q3
.2570.40 (0.62)0.39 (0.62)IPSS Q4
1.0000.99 (0.93)0.99 (0.92)IPSS Q5
.7060.38 (0.6200.37 (0.62)IPSS Q6
.1800.72 (0.77)0.73 (0.77)IPSS Q7
.7524.13 (2.10)4.13 (2.09)Total IPSS
1.0001.86 (1.10)1.86 (1.10)IPSS QOLc
aIPSS: International Prostate Symptom Score
bLUTS: lower urinary tract symptoms
cQOL: quality of life
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Table 4. Paired t test between paper and smartphone IPSSa in moderate LUTSb.
P valueSmartphone,
mean (SD)
Paper,
mean (SD)
.3181.93 (1.30)1.93 (1.30)IPSS Q1
.1031.81 (1.14)1.82 (1.14)IPSS Q2
.6311.87 (1.20)1.87 (1.19)IPSS Q3
.6551.53 (1.19)1.53 (1.19)IPSS Q4
.1272.74 (1.30)2.75 (1.31)IPSS Q5
.8191.35 (1.15)1.36 (1.15)IPSS Q6
1.0001.34 (1.01)1.34 (1.01)IPSS Q7
.43212.58 (3.32)12.59 (3.30)Total IPSS
.3182.99 (1.01)2.99 (1.02)IPSS QOLc
aIPSS: International Prostate Symptom Score
bLUTS: lower urinary tract symptoms
cQOL: quality of life
Table 5. Paired t test between paper and smartphone IPSSa in severe LUTSb.
P valueSmartphone,
mean (SD)
Paper,
mean (SD)
.3183.95 (1.15)3.96 (1.12)IPSS Q1
1.0003.38 (1.33)3.38 (1.33)IPSS Q2
1.0003.81 (1.26)3.81 (1.26)IPSS Q3
1.0003.09 (1.49)3.09 (1.49)IPSS Q4
.1584.46 (0.79)4.46 (0.79)IPSS Q5
1.0003.29 (1.52)3.29 (1.51)IPSS Q6
1.0002.51 (1.28)2.51 (1.28)IPSS Q7
.08324.44 (3.58)24.45 (3.58)Total IPSS
.3184.43 (0.82)4.45 (0.81)IPSS QOLc
aIPSS: International Prostate Symptom Score
bLUTS: lower urinary tract symptoms
cQOL: quality of life
Reliability Test With Interclass Correlation Coefficient
(ICC) Test
Reliability was assessed using the ICC and a two-way random
effect model, assuming a single measurement and absolute
agreement. A significant correlation was noted in the total group
(ICC=.935, P<.001). The mild, moderate, and severe LUTS
groups also showed significant correlations (ICCs =.616, .549,
and .548 respectively, all P values <.001) (Table 6).
Table 6. Reliability test of paper and smartphone versions of the IPSSa.
P value95% CIInterclass correlation coefficient
UpperLower
<.0010.9410.927.935Total
<.0010.6590.571.616Mild LUTSb
<.0010.6020.492.549Moderate LUTS
<.0010.6250.462.548Severe LUTS
aIPSS: International Prostate Symptom Score
bLUTS: lower urinary tract symptoms
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Compliance
For compliance, we created two questions that asked, “Which
method would you be willing to use to complete the assessment
more easily?” and “Which method would you prefer?” In the
examination of feasibility, 760 (48.07%, 760/1581) participants
replied that the smartphone version was more feasible, 420
(26.56%, 420/1581) participants replied that the paper version
was more feasible, and 301 (19.03%, 301/1581) participants
replied that both of the versions were feasible. With regard to
preference, 820 (51.86%, 820/1581) participants preferred the
smartphone version, 320 participants (20.24%, 320/1581)
preferred the paper version, and 356 (22.51%, 356/1581)
participants showed no preference. For the two questionnaires,
the results showed significant differences according to age
(P<.001).
Discussion
Principal Findings
The objective of this study was to compare two different
methods for diagnostic assessment via screening questionnaires.
The overall hypothesis of this study was that a smartphone
application of IPSS would show the same efficacy in real clinical
use as a diagnostic questionnaire. This study was the first to
show the clinical use of a smartphone questionnaire application
in the field of urology (Figures 2-4).
The recent remarkable increase in the adoption of smartphones
enables not only easy communication, but also the possibility
of utilizing devices in diverse settings, including health care.
There have been several studies using smartphone applications
of sleep questionnaires, including the Epworth Sleepiness Scale,
the Berlin questionnaire, and the STOP BANG questionnaire
[10]. In psychiatric disease and serious mental illness,
smartphone-based questionnaires for monitoring have shown
better compliance than other types of questionnaires.
Ambulatory monitoring of symptoms using smartphone
applications represents a feasible and valid way of assessing
psychotic status for research and clinical management [11,16].
Smartphone application questionnaires have also been used in
a cardiac rehabilitation population for measuring physical
activity with demonstrated validity and reliability [12].For
clinical application as a medical device, a smartphone-based
application has been used for actigraphy recording and audio
recording in sleep disorders [10]. However, none were
statistically validated by a comparison with the paper version
of the questionnaire by a non-inferior trial with the hypothesis
that the smartphone version of the questionnaire could be as
effective as the paper version of the questionnaire. Little is
known about the strengths and limitations of smartphone
application questionnaires in the screening or monitoring of
diseases, especially in the field of urology. Only one study has
shown the validity and reliability of a smartphone application
for the assessment of penile deformity in Peyronie’s disease
[17]. There are several urologic applications such as “Bladder
Pal”, “Prostate Pal”, “Get Bladder Fit”, and “UroApp”. Prostate
Pal provides an easily accessible tool for recording intake and
output, AUA score, and PSA level, but this application showed
no validity.
The main issue in mobile research is ensuring the security of
patient data. It is an important problem and it has been argued
that it is not safe for health care clinicians to have access to
patient information from a handheld device [18]. This is the
main reason that we designed this Web-based application to
ensure that patient information and clinical data were not saved
on patients’ own smartphones, but transferred directly to the
main server. Administration of the server was only performed
by clinicians and, after data were transferred to the hospital
server, the records were removed.
The merits of the clinical use of a smartphone application are
the possibility of yielding a great number of data points,
requiring less time, and more positive compliance by participants
than conventional methods, including paper, telephone, and
email methods. From a technical view, a smartphone application
has computing power, a touch screen, third-party application
development and distribution, and high-speed data transfer.
Smartphones can effectively use real-time upload and backup,
which can prevent data loss [19,20]. With regard to feasibility,
users believed smartphones were easier to use than a
conventional paper system in a study of an Android-based
application for men’s health [19,21]. In terms of time
consumption, a smartphone application has merits over paper
questionnaires and Web-based research [12,22,23]. Moreover,
increased access and availability to smartphone communication
increases the potential for large scale surveys in
population-based studies.
We developed this application for the Android operating system.
The two main discriminatory factors for determining the
operating system were the widespread popularity and
homogeneity of the smartphone hardware. We adopted the
Android operating system because the number of its users is
rapidly growing. With regard to homogenous hardware safety,
the iPhone may be a better option.
There are regulatory barriers to the clinical application of
smartphone-based medical devices, but smartphone-based
questionnaires such as our application are considered Class I
devices by the FDA [24,25]. Class I devices represent general
devices that are not designed for use in supporting or sustaining
life nor are of considerable importance in preventing impairment
to human life and have the least demanding restrictions of the
three FDA device classes. In recent guidelines, the FDA
classified Medical Device Data System (MDDS) software as
Class I, because it transfers, stores, converts, or displays medical
device data without providing analysis, alarms, or active patient
monitoring. This latest set of MDDS guidelines came after the
European Commission decision that most applications would
be classified under Class I. Our application is a simple substitute
for a paper-based questionnaire and does not involve analysis
of data, alarms, or active patient monitoring.
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Figure 2. Screenshot of the IPSS Android smartphone application. IPSS: International Prostate Symptom Score.
Figure 3. IPSS question 1 and ending screen in the smartphone application. IPSS: International Prostate Symptom Score.
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Figure 4. Registered IPSS scores are automatically transferred to main server. IPSS: International Prostate Symptom Score.
Limitations
This study has several limitations. First, there could be selection
bias in this study. Some patients reported a mild negative
reaction to the questionnaire method. It is possible that
smartphone assessment is less suitable in certain subgroups of
patients. Some groups, including older-aged people, may use
this mobile technology less than others and find it to be a barrier.
However, it is estimated that 80-90% of the population will
have a smartphone within 10 years [26]. Considering the rapid
increase in the use of smartphones, older-aged people will
increasingly come to be familiar with smartphones.
There is also skepticism over the possible differences between
self-reported measures and clinician-based ratings. The IPSS
was originally developed as a self-reported questionnaire and
self-report measures may be time and cost-saving methods.
Although we demonstrated the validity of a smartphone
application of the IPSS by quantitative analysis, concerns still
remain regarding the quality of the analysis, including data
recording, data entry, reliability, time consumption, and costs.
Our application does not contain open-ended questions, and
therefore we did not examine issues of quality, except for
compliance and satisfaction rates. A more streamlined graphical
and colorful user interface may lead to better compliance for
participants for both screening and monitoring.
We divided patients into three groups based on the severity of
their symptoms as ascertained by their QOL scores: mild (0-2),
moderate (3-4), and severe (5-6). This classification was
arbitrary. We did not consider sociodemographic factors of
patients that could impact the development of LUTS.
Nevertheless, to our knowledge, this is the first study to
demonstrate the validity of a smartphone version of the IPSS
by scientific methods.
Conclusions
In summary, a smartphone application of the IPSS has validity
and reliability, which means that it is not inferior to the paper
version of the IPSS. Further research is needed to test its efficacy
in the monitoring of LUTS. Future studies are needed to
demonstrate its role in consecutive monitoring and also its
usefulness in cost savings and data collection.
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